Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis

doi:10.1186/s13063-021-05311-8

Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
文章编号	376
期刊	Trials
卷	22
期	1
DOI	https://doi.org/10.1186/s13063-021-05311-8
出版状态	已出版 - 12月 2021
已对外发布	是

!!!ASJC Scopus Subject Areas

药学（医学）
医学（杂项）

访问文件

10.1186/s13063-021-05311-8

其它文件与链接

指纹

探究 'Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis' 的科研主题。它们共同构成独一无二的指纹。

引用此

(2021). Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis. Trials, 22(1), 文章 376. https://doi.org/10.1186/s13063-021-05311-8

Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis.
在: Trials, 卷 22, 号码 1, 376, 12.2021.

科研成果: 期刊稿件 › 文章 › 同行评审

2021, 'Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis', Trials, 卷 22, 号码 1, 376. https://doi.org/10.1186/s13063-021-05311-8

Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis. Trials. 2021 12月;22(1):376. doi: 10.1186/s13063-021-05311-8

/ Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock : study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis. 在: Trials. 2021 ; 卷 22, 号码 1.

@article{103a0cd5338a4aceb1adadb1c93c232f,

title = "Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis",

keywords = "Capillary leakage, Colloids, Critically ill, Fluid management, Gelatine, Resuscitation, Sepsis",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s13063-021-05311-8",

language = "English",

volume = "22",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock

T2 - study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial: GENIUS—Gelatine use in ICU and sepsis

PY - 2021/12

Y1 - 2021/12

KW - Capillary leakage

KW - Colloids

KW - Critically ill

KW - Fluid management

KW - Gelatine

KW - Resuscitation

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=85107139824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107139824&partnerID=8YFLogxK

U2 - 10.1186/s13063-021-05311-8

DO - 10.1186/s13063-021-05311-8

M3 - Article

C2 - 34078421

AN - SCOPUS:85107139824

SN - 1745-6215

VL - 22

JO - Trials

JF - Trials

IS - 1

M1 - 376

ER -